Volume | 560,814 |
|
|||||
News | - | ||||||
Day High | 26.00 | Low High |
|||||
Day Low | 24.85 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
PTC Therapeutics Inc | PTCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.79 | 24.85 | 26.00 | 25.21 | 25.41 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
9,663 | 560,814 | $ 25.43 | $ 14,260,782 | - | 17.53 - 59.84 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:20:00 | formt | 270 | $ 25.21 | USD |
PTC Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.93B | 76.61M | - | 1.07B | -626.6M | -8.18 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
PTC Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTCT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 25.50 | 26.49 | 24.01 | 25.30 | 1,363,898 | -0.29 | -1.14% |
1 Month | 28.18 | 29.85 | 24.01 | 26.58 | 840,087 | -2.97 | -10.54% |
3 Months | 26.52 | 32.905 | 23.58 | 27.64 | 867,779 | -1.31 | -4.94% |
6 Months | 23.09 | 32.905 | 17.53 | 25.63 | 1,067,427 | 2.12 | 9.18% |
1 Year | 55.00 | 59.84 | 17.53 | 30.61 | 1,042,896 | -29.79 | -54.16% |
3 Years | 46.16 | 59.84 | 17.53 | 36.57 | 763,418 | -20.95 | -45.39% |
5 Years | 36.61 | 70.82 | 17.53 | 40.94 | 716,559 | -11.40 | -31.14% |
PTC Therapeutics Description
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |